Deutsche Bank Upgrades RYN to Hold, Market Discounting Specialty Cellulose Downside and
Rayonier CFO to Present at Bank of America Merrill Lynch 2013 US Basic Materials Conference...
We heard from Smith, Katzenstein & Jenkins LLP yesterday (11/19/13), the attorneys representing REV Preferred (A) shareholders. The settlement's distribution appears to be in the works. The tentative date for distribution is estimated to be December 31, 2013. If you are like me a former Preferred A shareholder whose stock was redeemed in October 2013, be sure your name is with REV's transfer agent to ensure eligibility for a distribution. Good luck (and frankly, good riddance to REV!).
OK - Slight miss on revenues; margins up by 1%; macro-picture in emerging mkts./So. Europe still remains (understandably) a concern for any multi-national; CSCO making in-roads on cloud computing space; div./buy-backs grow and continue to occur; Chambers / strategy remains focused. Recognize that CSCO is a large-cap value (vs. growth) investment...patience will be (eventually) rewarded.
Dear Dr. Horendo: Your comment is spot-on. If I see another one of these Cialis commercials on CNBC...(fill-in the blank). By the by, enough of the "Axiron" commercials as well and their gazillion disclaimers!
I agree with the earlier comment regarding AA being subject to a "bear raid." This is completely unjustified. The sell-off seems unreasonable considering we have been experiencing a rotational movement into industrials. I've held this stock for years and will agree AA has seen better days but AA management (i.e. Klaus Kleinfeld) deserves a whole lot better. For long-term investors, fasten your seat belts and keep the faith, (although, it's easy to become an agnostic). RJ
Thanks for your comments. Glad to know the issue appears more industry versus company-specific. Appreciate the follow-up. RJ
Great question! Didn't Goldman recently have IP on its Buy (w conviction) list? Also, IP's fundamentals (projected earnings, revenues) still appear on track unless IP's business in emerging markets / Europe is starting to falter. A 3.9% sell-off today just doesn't appear justified. Any color (aside from a technical chart explanation) would be appreciated. RJ
Deutsche Bank rated RYN a SELL this morning (10/25) anticipating a sharp drop in cellulose prices (Performance Fiber segment). Unsure whether this will have a material impact on RYN going forward into 2014. Deutsche suggests that growth in RYN's two other segments, Forest Resources and Real Estate, may mitigate shortfall. RYN management in conference call assures they are on "track for another strong year." Assuming dividend remains safe, why such a sharp sell-off? More color needed and would be appreciated.
Held REVZP for 4-years which was called on October 8th. Prior to mandatory call, SEC fined Revlon and a class action lawsuit was apparently argued and settled in the Court of Chancery of the State of Delaware. We were never notified by the class action attorneys (Smith Katzenstein & Jenkins, LLP) and have written them. Our letters go unanswered. The (somewhat coerced) conversion from REV common to REVZP was raw deal for shareholders. Any info would be greatly appreciated....Suffered 80% loss...Thank you.
Thanks to all for the input. EXC scheduled to report October 30th. Consensus @.67cents (high @ .74 and low @ .63). Fingers remain crossed.
Was it Morgan Keegan or Morgan Stanley that downgraded EXC? Also, does anyone have any information for the basis for the downgrade and the price target? Any color as to whether the current dividend is covered or potentially subject to another reduction would be appreciated.